.Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01C_HypothalamicHormones.H01CA02_Nafarelin.Nafarelin .Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01C_HypothalamicHormones.H01CA02_Nafarelin.Nafarelin| name: | Nafarelin | |
| ATC code: | H01CA02 | route: | intranasal |
| compartments: | 1 | |
| dosage: | 200 | mg |
| volume of distribution: | 195.5 | L |
| clearance: | 1.4 | L/min |
| other parameters in model implementation | ||
Nafarelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist used mainly for the treatment of endometriosis and central precocious puberty. It is administered as a nasal spray and is approved for medical use in various countries.
Healthy adult volunteers, both sexes, standard dosing for endometriosis